These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2531804

  • 1. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ, Hubbard AK, Huxtable RJ.
    J Toxicol Environ Health; 1989; 28(4):445-60. PubMed ID: 2531804
    [Abstract] [Full Text] [Related]

  • 2. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
    Mathew R, Gloster ES, Altura BT, Altura BM.
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
    [Abstract] [Full Text] [Related]

  • 3. Na+/K(+)-adenosine triphosphatase activity of pulmonary arteries after intoxication with the pyrrolizidine alkaloid, monocrotaline.
    Shubat PJ, Bowers RJ, Huxtable RJ.
    J Pharmacol Exp Ther; 1990 Jan; 252(1):70-6. PubMed ID: 2153811
    [Abstract] [Full Text] [Related]

  • 4. Serum copper concentration as an index of cardiopulmonary injury in monocrotaline-treated rats.
    Molteni A, Ward WF, Ts'ao CH, Fitzsimons EJ.
    Ann Clin Lab Sci; 1988 Jan; 18(6):476-83. PubMed ID: 3149170
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
    Todd L, Mullen M, Olley PM, Rabinovitch M.
    Pediatr Res; 1985 Jul; 19(7):731-7. PubMed ID: 3161000
    [Abstract] [Full Text] [Related]

  • 6. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
    Mathew R, Altura BT, Altura BM.
    Magnesium; 1989 Jul; 8(2):110-6. PubMed ID: 2526910
    [Abstract] [Full Text] [Related]

  • 7. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE, Sprugel KH, Hadley KB, Roth RA.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [Abstract] [Full Text] [Related]

  • 8. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
    Molteni A, Ward WF, Ts'ao CH, Hinz JM.
    Biochem Pharmacol; 1989 Aug 01; 38(15):2411-9. PubMed ID: 2547380
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats.
    Sugita T, Hyers TM, Dauber IM, Wagner WW, McMurtry IF, Reeves JT.
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Feb 01; 54(2):371-4. PubMed ID: 6219974
    [Abstract] [Full Text] [Related]

  • 18. Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
    Hilliker KS, Roth RA.
    Br J Pharmacol; 1984 Jun 01; 82(2):375-80. PubMed ID: 6234044
    [Abstract] [Full Text] [Related]

  • 19. The platelet thromboxane inhibitor, dazmegrel, does not reduce monocrotaline-induced pulmonary hypertension.
    Langleben D, Carvalho AC, Reid LM.
    Am Rev Respir Dis; 1986 May 01; 133(5):789-91. PubMed ID: 3085563
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jul 01; 109(3):421-31. PubMed ID: 1830177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.